|Dr. Carol Remmer Angle|
Carol Remmer Angle, 2012.
|Born||December 20, 1927|
|Occupation||Pediatrician, Nephrologist, Toxicologist|
|Spouse(s)||Dr. William Angle (deceased 1993)|
|Children||Dr. Marcia Angle|
Dr. John F. Angle
Carol Remmer Position can be an American pediatrician, nephrologist, and toxicologist. Dr. Position is recognized as among the nation’s leading experts on business lead poisoning. She actually is teacher emeritus in the University or college of Nebraska INFIRMARY (UNMC) in Omaha, Nebraska. Dr. Position became a member of UNMC in 1971 and was among the 1st ladies to serve as seat of an educational medical division (pediatrics). She also offered as main of pediatric nephrology, movie director from the pediatric rigorous care device, and movie director of medical toxicology. In 1957, Dr. Position along with Dr. Matilda McIntire, founded among the nation’s 1st poison control centers. Dr. Position is usually a founding member and a previous president from the American Association of Poison Control Centers. For forty years, Dr. Position served as a specialist for NIEHS, Country wide Institutes of Health insurance and U.S. Environmental Safety Agency panels looking into rock toxicity. Dr. Position continues like a toxicology specialist, reviewer and editor.
Education and training
Wellesley University; Cornell Medical College; New York Medical center Pediatric, Internship and Residency; School of Nebraska Medical center, Residency
Offices held and honors
Movie director, Medical Education, Children's Memorial Medical center, Omaha, Nebraska, 1954-1967 Movie director, Nebraska Get better at Poison Control Middle, 1957-1966 State Planner, Nebraska Get better at Poison Control Middle, 1957-1966 Movie director, Pediatric Renal Center, College or university of Nebraska Medical center & Treatment centers, 1966-1984 Movie director, Pediatric Intensive Treatment Unit, School of Nebraska Medical center, 1968-1974 Plan Chairman, American Association of Poison Control Centers, 1977-1979 Teacher, Section of Pediatrics, School of Nebraska University of Medication, 1971-1998 Director, Country wide Foundation Birth Flaws Treatment Middle, Children's Memorial Medical center, 1974-1981 Member, Toxicology Advisory Plank, U.S. Customer Product Safety Fee, 1978-1982 Chairman, Section of Pediatrics, School of Nebraska University of Medication, 1981-1985 Member, Country wide Advisory Environmental Wellness Sciences Council, NIH, 1984-1987 Movie director, Clinical Toxicology, School of Nebraska INFIRMARY, 1985-1998 Editor-in-Chief, Journal of Toxicology - Clinical Toxicology, 1989-2002 Teacher Emeritus, Section of Pediatrics, School of Nebraska University of Medication, 1999–present Honor Prize, Matthew J. Ellenhorn Prize, 2003 Honor Prize, School of Nebraska INFIRMARY Legends Prize, 2008 
Published works (partial list)
Position, C. R. (1954). "Congenital bowing and angulation of lengthy bone fragments". Pediatrics. 13 (3): 257–268. PMID 13155074. Position, C. R. (1963). "Poison Control Outlines: Toxicity of Insecticides and Herbicides". The Nebraska condition medical journal. 48: 644–646. PMID 14089947. Position, C. R.; McIntire, M. S. (1964). "Lead Poisoning During Being pregnant. Fetal Tolerance of Calcium mineral Disodium Edetate". American journal of illnesses of kids (1960). 108: 436–439. PMID 14186666. doi:10.1001/archpedi.1964.02090010438016. Position CR (1966). "Severe renal failing". J Lancet. 86: 355–362. Position, C. R.; McIntire, M. S. (1966). "Evaluation of the poison information middle". The Journal-lancet. 86 (7): 363–365. PMID 5939583. Position, C. R.; McIntire, M. S.; Moore, R. C. (1967). "Cloverleaf skull: Kleeblattschädel-deformity symptoms". American journal of illnesses of kids (1960). 114 (2): 198–202. PMID 4951548. doi:10.1001/archpedi.1967.02090230128018. Position CR, McIntire MS, Zetterman RA (1968). "CNS symptoms in years as a child poisoning". Clin Toxicol. 1: 19–29. Position CR, McIntire MS, Meile R (1968). "Neurologic sequelae of poisoning in kids". J Pediat. 73: 531–539. doi:10.1016/s0022-3476(68)80268-9. Position, C. R.; McIntire, M. S. (1968). "Continual dystonia within a brain-damaged kid after ingestion of phenothiazine". The Journal of Pediatrics. 73 (1): 124–126. PMID 5658620. doi:10.1016/s0022-3476(68)80050-2. Position, C. R.; Glyn, M. (1969). "The worthiness of the pediatric high strength care device". The Nebraska condition medical journal. 54 (11): 737–740. PMID 4242184. Position CR (1971). "Symposium on iron poisoning". Clin Tox. 4: 525–527. Position, C. R.; McIntire, M. S. (1974). "Reddish colored cell lead, entire bloodstream lead, and reddish colored cell enzymes". Environmental Wellness Perspectives. 7: 133–137. PMC 1475113 . PMID 4364646. doi:10.1289/ehp.747133. Position, C. R.; Wermers, J. (1974). "Individual poisoning with flea-dip focus". Journal from the American Vet Medical Association. 165 (2): 174–175. PMID 4837827. Position, C. R.; McIntire, M. S.; Vest, G. (1975). "Bloodstream business lead of Omaha college children--topographic relationship with industry, visitors and casing". The Nebraska medical journal. 60 (4): 97–102. PMID 48205. Position, C. R. (1975). "Locomotor abilities and school mishaps". Pediatrics. 56 (5): 819–822. PMID 1196740. Position, C. R.; McIntire, M. S.; Brunk, G. (1977). "Aftereffect of anemia on bloodstream and tissue business lead in rats". Journal of Toxicology and Environmental Wellness. 3 (3): 557–563. PMID 926207. doi:10.1080/15287397709529587. Position CR, Trembath EJ, Strond W (1977). "The myelodysplasia and hydrocephalus plan in Nebraska: A 15 season review of price and benefits, Recreation area I.". Nebr Med J. 62: 359–361. Position, C. R.; Trembath, E. J.; Strond, W. L. (1977). "The myelodysplasia and hydrocephalus plan in Nebraska: A 15 season overview of costs and benefits". The Nebraska medical journal. 62 (11): 391–393. PMID 412114. Position CR and McIntire MS: Business lead, mercury and cadmium: toxicity in kids. Paediatrician 6:204-225, 1977. Position, C. R.; McIntire, M. S. (1978). "Low level business lead and inhibition of erythrocyte pyrimidine nucleotidase". Environmental analysis. 17 (2): 296–302. PMID 233817. doi:10.1016/0013-9351(78)90032-4. Position, C. R.; McIntire, M. S. (1979). "Environmental business lead and kids: The Omaha research". Journal of Toxicology and Environmental Wellness. 5 (5): 855–870. PMID 583166. doi:10.1080/15287397909529795. Position, C. R.; Stohs, S. J.; McIntire, M. S.; Swanson, M. S.; Rovang, K. S. (1980). "Lead-induced deposition of erythrocyte pyrimidine nucleotides in the rabbit". Toxicology and used pharmacology. 54 (1): 161–167. PMID 7394785. doi:10.1016/0041-008x(80)90017-4. Position, C. R. (1981). "The Division of Pediatrics, University or college of Nebraska INFIRMARY". The Nebraska medical journal. 66 (3): 53–54. PMID 7231593. Position, C. R.; McIntire, M. S.; Swanson, M. S.; Stohs, S. J. (1982). "Erythrocyte nucleotides in children--increased bloodstream business lead and cytidine triphosphate". Pediatric study. 16 (4 Pt 1): 331–334. PMID 7079004. doi:10.1203/00006450-198204000-00019. Position, C. R.; O'Brien, T. P.; McIntire, M. S. (1983). "Adolescent self-poisoning: A nine-year followup". Journal of developmental and behavioral pediatrics : JDBP. 4 (2): 83–87. PMID 6874961. doi:10.1097/00004703-198306000-00001. Position, C. R.; Marcus, A.; Cheng, I. H.; McIntire, M. S. (1984). "Omaha child years bloodstream business lead and environmental business lead: A linear total publicity model". Environmental study. 35 (1): 160–170. PMID 6489285. doi:10.1016/0013-9351(84)90123-3. Position, C. R.; Swanson, M. S.; Stohs, S. J.; Markin, R. S. (1985). "Irregular erythrocyte pyrimidine nucleotides in uremic topics". Nephron. 39 (3): 169–174. PMID 2983249. doi:10.1159/000183366. Position, C. R.; Kuntzelman, D. R. (1989). "Improved erythrocyte protoporphyrins and bloodstream business lead—a pilot research of childhood development patterns". Journal of Toxicology and Environmental Wellness. 26 (2): 149–156. PMID 2921779. doi:10.1080/15287398909531241. Position, C. R.; Thomas, D. J.; Swanson, S. A. (1990). "Toxicity of cadmium to rat osteosarcoma cells (ROS 17/2.8): Protective aftereffect of 1 alpha,25-dihydroxyvitamin D3". Toxicology and used pharmacology. 103 (1): 113–120. PMID 2315924. doi:10.1016/0041-008x(90)90267-x. Position, C. R.; Thomas, D. J.; Swanson, S. A. (1990). "Lead inhibits the basal and activated responses of the rat osteoblast-like cell collection ROS 17/2.8 to at least one 1 alpha,25-dihydroxyvitamin D3 and IGF-I". Toxicology and used pharmacology. 103 (2): 281–287. PMID 2330589. doi:10.1016/0041-008x(90)90230-r. Position CR, Thomas DJ, Swanson SA (1993). "Osteotoxicity of cadmium and business lead in HOS TE 85 and ROS 17/2.8 cells: Regards to metallothionein induction and mitochondrial binding". BioMetals. 5: 179–184. Position, C. R.; Manton, W. I.; Stanek, K. L. (1995). "Steady isotope recognition of lead resources in preschool children--the Omaha Research". Journal of toxicology. Clinical toxicology. 33 (6): 657–662. PMID 8523488. doi:10.3109/15563659509010624. Position CR, Swanson SA: Arsenite enhances homocysteine-induced proliferation of fibroblasts in human being aortic smooth muscle mass cells in B12 (Cobalamin) lacking press. Submitted to Environmental Wellness Perspectives, July 1997. Position, C. R. (2002). "Pitfalls of relationship of childhood bloodstream business lead and cognitive advancement". Journal of toxicology. Clinical toxicology. 40 (4): 521–522. PMID 12217008.